Latest Reimbursement News

Page 3 of 50
Haranga Resources has moved its Lincoln Gold Project closer to a formal redevelopment study after completing underground access works, securing adjacent land and returning a high-grade result from the first Phase 2 hole. The company ended September with $3.33 million in cash as it weighs the cost and scale of a potential restart.
Maxwell Dee
Maxwell Dee
30 Oct 2026
Epiminder has enrolled its 100th patient in the DETECT US epilepsy study ahead of schedule, while maintaining A$65.1 million in cash and no borrowings. The company says those reserves can fund clinical development and commercialisation work well into 2028.
Victor Sage
Victor Sage
30 Oct 2026
OncoSil Medical enters FY27 with FDA approval for its cancer device, rising quarterly revenue and fresh institutional funding, but its U.S. opportunity still depends on reimbursement and a tightly controlled initial rollout. Cash rose to A$8.7 million after the capital raise, while operating cash use remained substantial.
Victor Sage
Victor Sage
30 Oct 2026
Parkway Corporate delivered record quarterly revenue of $7.71 million and $1.08 million in operating cash flow as its mine dewatering contract expanded to about $2.1 million. The company also advanced its Queensland brine project, although its next test is turning approvals and technology development into funded commercial infrastructure.
Victor Sage
Victor Sage
30 Oct 2026
Tissue Repair has increased its US Phase III chronic wound trial to approximately 112 randomised patients while shifting focus towards an April 2027 FDA 510(k) submission. The company also reported $4.74 million in cash, Australian availability of all three TR Pro+ formats and a planned $1 million share buy-back.
Ada Torres
Ada Torres
29 Oct 2026
Cyclopharm has reported record third-quarter US Technegas revenue of A$1.62 million, with 76% generated by recurring consumable orders. Its installed base and hospital pipeline expanded sharply after new clinical guidelines preferred Technegas when available, while quarterly cash burn fell to A$0.9 million.
Ada Torres
Ada Torres
29 Oct 2026
IperionX has validated titanium powder capacity above 200 tonnes per annum and lifted quarterly production to 8.7 tonnes, while a new U.S. Army task order funds further manufacturing scale-up. The company ended September with US$63.0 million in cash and US$33.7 million of obligated government funding still available for reimbursement.
Victor Sage
Victor Sage
29 Oct 2026
Orbit Resources has extended its Lewis Ponds exploration story with new sulphide intersections, an out-of-resource Quarry Lode result and improved metallurgical prospects. The progress comes alongside a cash balance of A$1.743 million, equivalent to just 0.89 quarters of funding at the reported expenditure rate.
Maxwell Dee
Maxwell Dee
29 Oct 2026
INOVIQ will restart its EXO-OC ovarian cancer program through a staged optimisation and verification process after an independent review found sample collection and handling were the main sources of variability. The company is targeting US laboratory-developed test readiness in the first half of 2028, while a leadership change adds another moving part.
Ada Torres
Ada Torres
29 Oct 2026
PainChek is concentrating its commercial effort on residential aged care after signing new US and UK business, including an 808-licence Sabra expansion and an approximately 1,800-licence Hallmark contract. Revenue and retention improved, but activated ARR growth slowed to 1.2% for the quarter and cash covered an estimated 2.5 quarters of historical operating outflows.
Victor Sage
Victor Sage
28 Oct 2026
E79 Gold is preparing to start more than 12,000 metres of drilling at its Cue Gold Project in November, subject to final heritage clearance. The explorer ended September with $1.946 million in cash as it moves from target generation to field testing.
Maxwell Dee
Maxwell Dee
28 Oct 2026
Ballymore Resources has reported further high-grade silver-lead-zinc-indium mineralisation at Torpy’s while advancing underground work and exploration at Dittmer. The stronger exploration picture comes with a sharper funding question: the company held $2.67 million in cash at quarter end, equivalent to an estimated 1.2 quarters of funding at the reported spending rate.
Maxwell Dee
Maxwell Dee
27 Oct 2026

Browse the archive

Full archive